Matthew Joshua Wright, MD | |
2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404-3239 | |
(423) 698-3309 | |
(423) 624-6355 |
Full Name | Matthew Joshua Wright |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 19 Years |
Location | 2341 Mccallie Ave, Chattanooga, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700067667 | NPI | - | NPPES |
110631 | Medicaid | AL | |
582292601D MMSC | Medicaid | GA | |
5911873 | Medicaid | NC | |
582292601E PH | Medicaid | GA | |
4225390 | Other | TN | BLUE CROSS BLUE SHIELD OF TN |
582292601B MH | Medicaid | GA | |
1513159 | Medicaid | TN | |
582292601C PEH | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | MD41563 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Hamilton Medical Center | Dalton, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Georgia Anesthesia Services Pc | 2769800515 | 38 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Inter Press Service examines efforts to end female genital mutilation (FGM) in Liberia. "Through cooperative efforts with traditional leaders, the government of Liberia is quietly moving to ... bring an end to female genital cutting in Liberia," IPS writes.
Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).
› Verified 7 days ago
Entity Name | American Anesthesiology Of Tennessee Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609822998 PECOS PAC ID: 9931001922 Enrollment ID: O20181207001177 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Inter Press Service examines efforts to end female genital mutilation (FGM) in Liberia. "Through cooperative efforts with traditional leaders, the government of Liberia is quietly moving to ... bring an end to female genital cutting in Liberia," IPS writes.
Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).
› Verified 7 days ago
Entity Name | North Georgia Anesthesia Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114545431 PECOS PAC ID: 2769800515 Enrollment ID: O20200911000134 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Inter Press Service examines efforts to end female genital mutilation (FGM) in Liberia. "Through cooperative efforts with traditional leaders, the government of Liberia is quietly moving to ... bring an end to female genital cutting in Liberia," IPS writes.
Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Matthew Joshua Wright, MD Po Box 3549, Chattanooga, TN 37404-0549 Ph: (423) 698-3309 | Matthew Joshua Wright, MD 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404-3239 Ph: (423) 698-3309 |
News Archive
Frequent episodes of severe pain occur in patients with sickle cell disease (SCD) and require treatment with potent opioid medications. A new study published in The Journal of Pain reports that SCD patients clear morphine from their blood stream quickly and, therefore, require high doses to achieve optimal analgesia.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
Cylene Pharmaceuticals today announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia have established, for the first time, that RNA Polymerase I (Pol I) activity is essential for cancer cell survival and that its inhibition selectively activates p53 to kill tumors. Published today in Cancer Cell, the findings show that Cylene's Pol I inhibitor, CX-5461, selectively destroys cancer by activating p53 in malignant but not in normal cells.
Inter Press Service examines efforts to end female genital mutilation (FGM) in Liberia. "Through cooperative efforts with traditional leaders, the government of Liberia is quietly moving to ... bring an end to female genital cutting in Liberia," IPS writes.
Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).
› Verified 7 days ago
Laura L Westbrook, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 975 E. Third Street, Chattanooga, TN 37403 Phone: 423-778-7608 Fax: 423-778-2360 | |
Brett Escarza, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Dr. Kyle V Roach, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Dr. Gary Daniel Smith, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Dr. Colin Riley Clanton, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Dr. Steven M Truelove, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Brian D Johnson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 975 E Third St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 |